Mednet Logo
HomePulmonologyQuestion

In patients with RA on methotrexate and a TNF inhibitor who develop PJP pneumonia, how long do you hold immunosuppression before restarting therapy?

1
1 Answers
Mednet Member
Mednet Member
Rheumatology · Washington University Physicians

I would typically hold immunosuppression until the patient has completed therapy unless they had significant respiratory failure, in which case I would await full recovery. The patient should be placed on appropriate PJP prophylaxis prior to resuming therapy.

Register or Sign In to see full answer

In patients with RA on methotrexate and a TNF inhibitor who develop PJP pneumonia, how long do you hold immunosuppression before restarting therapy? | Mednet